Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark
Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)
DOI: 10.1111/bcpt.70298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 30.08.2026. Verfasst von Heidi Sonne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden, Det Obelske Familiefond.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Geographic variation in ADHD treatment and diagnosis among children and adolescents is well documented, yet the system‐level factors driving such differences remain poorly understood. We examined nationwide patterns of ADHD medication use and diagnoses in Denmark in 2024 and assessed whether municipal socioeconomy, regional hospital waiting times or private child psychiatrist capacity contributed to geographic variation. In this register‐based cross‐sectional study, we included all Danish residents aged 4–17 years using data from national registers. Pharmacological treatment was defined as at least one redeemed prescription for ADHD drugs, and diagnosis was defined as at least one hospital contact with ICD‐10 codes F90.x/F98.8. Prevalence was calculated overall and stratified by sex and age, with associations explored using Spearman's rank correlations and regression analyses. ADHD medication prevalence varied sixfold across municipalities (9.6–58 per 1000), with parallel variation in diagnoses (15–74 per 1000) and the largest differences observed among adolescents. Municipal socioeconomic status was weakly and inversely correlated with medication use (ρ = −0.20, p = 0.049), but not diagnoses. Neither waiting times nor specialist capacity was significantly associated with either outcome. Marked geographic variation in ADHD medication use and diagnoses persists in Denmark despite a uniform healthcare framework, and appears largely unexplained by the system‐level factors examined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Psychiatry, North Denmark Region, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Department of Political Science and Public Management, University of Southern Denmark, Odense, Denmark.
- Mary Elizabeth's Hospital, University Hospital Copenhagen, Rigshospitalet, Denmark.
ORCID-Profile: Heidi Sonne, Anton Pottegård, Anna Sofie Kjærgaard Hansen, Mickael Bech, Helene Kildegaard
Förderung
- Novo Nordisk Fonden
- Det Obelske Familiefond
Zitieren
APA
Sonne, H., Pottegård, A., Hansen, A. S. K., Bech, M., & Kildegaard, H. (2026). Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70298
Vancouver
Sonne H, Pottegård A, Hansen ASK, Bech M, Kildegaard H. Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70298
BibTeX
@article{Sonne2026,
author = {Sonne, Heidi and Pottegård, Anton and Hansen, Anna Sofie Kjærgaard and Bech, Mickael and Kildegaard, Helene},
title = {Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {4},
doi = {10.1111/bcpt.70298}
}
EUVIMED